[go: up one dir, main page]

AR038036A1 - Nueva cepa de bacterias del acido lactico y composiciones comestibles, drogas y productos veterinarios que la contienen - Google Patents

Nueva cepa de bacterias del acido lactico y composiciones comestibles, drogas y productos veterinarios que la contienen

Info

Publication number
AR038036A1
AR038036A1 ARP020104992A ARP020104992A AR038036A1 AR 038036 A1 AR038036 A1 AR 038036A1 AR P020104992 A ARP020104992 A AR P020104992A AR P020104992 A ARP020104992 A AR P020104992A AR 038036 A1 AR038036 A1 AR 038036A1
Authority
AR
Argentina
Prior art keywords
drugs
products containing
edible compositions
cepa
lactic acid
Prior art date
Application number
ARP020104992A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simone Claudio De filed Critical Simone Claudio De
Publication of AR038036A1 publication Critical patent/AR038036A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)

Abstract

Se describe una nueva cepa de Streptococcus thermophilus spp. salivarius (depositada el 4 de diciembre de 2001 en la DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Alemania, con el No. de acceso DSM 14667) y composiciones comestibles, drogas y productos veterinarios que la contienen. El uso de dicha cepa es particularmente efectivo en la prevención / el tratamiento de la esteatosis hepática (hígado graso) y en la esteatosis hepática no alcohólica.
ARP020104992A 2001-12-21 2002-12-19 Nueva cepa de bacterias del acido lactico y composiciones comestibles, drogas y productos veterinarios que la contienen AR038036A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000763A ITRM20010763A1 (it) 2001-12-21 2001-12-21 Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.

Publications (1)

Publication Number Publication Date
AR038036A1 true AR038036A1 (es) 2004-12-22

Family

ID=11455924

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104992A AR038036A1 (es) 2001-12-21 2002-12-19 Nueva cepa de bacterias del acido lactico y composiciones comestibles, drogas y productos veterinarios que la contienen

Country Status (28)

Country Link
US (2) US7223591B2 (es)
EP (2) EP1652913A1 (es)
JP (2) JP4339124B2 (es)
KR (1) KR100934747B1 (es)
CN (2) CN1276970C (es)
AR (1) AR038036A1 (es)
AT (1) ATE335807T1 (es)
AU (1) AU2002367124B2 (es)
BR (1) BR0207397A (es)
CA (1) CA2457801C (es)
CY (1) CY1105402T1 (es)
DE (1) DE60213859T2 (es)
DK (1) DK1456351T3 (es)
EA (1) EA006688B1 (es)
ES (1) ES2271384T3 (es)
HU (1) HU225787B1 (es)
IL (2) IL161995A0 (es)
IS (1) IS2645B (es)
IT (1) ITRM20010763A1 (es)
MA (1) MA27685A1 (es)
MX (1) MXPA03007483A (es)
NO (1) NO329645B1 (es)
NZ (1) NZ533696A (es)
PL (1) PL207395B1 (es)
PT (1) PT1456351E (es)
UA (1) UA80546C2 (es)
WO (1) WO2003055984A1 (es)
ZA (1) ZA200405763B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US20050239706A1 (en) * 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
CA2662710A1 (en) * 2006-09-07 2008-03-13 Mcgill University Oral polymeric membrane feruloyl esterase producing bacteria formulation
CN101969967A (zh) * 2008-01-15 2011-02-09 札幌啤酒株式会社 酒精性肝病抑制剂
WO2010108865A1 (en) 2009-03-25 2010-09-30 Chr. Hansen A/S Use of probiotics to ameliorate diet-induced insulin resistance
TW201106957A (en) * 2009-08-31 2011-03-01 Synbio Tech Inc The new strain of Lactobacillus plantarum LP28 and its use in treating allergy
CN102702372B (zh) * 2010-10-28 2013-11-27 内蒙古蒙牛乳业（集团）股份有限公司 一种嗜热链球菌胞外多糖及其制备和检测方法
KR101238836B1 (ko) 2011-05-17 2013-03-04 삼육대학교산학협력단 혼합 유산균을 포함하는 비만 또는 비만 관련 질환 치료 또는 예방용 약제학적 조성물 또는 식품 조성물
EP2609814A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
JP6061530B2 (ja) * 2012-07-25 2017-01-18 株式会社ヤクルト本社 Ｎａｓｈ予防治療剤
ES2770401T3 (es) 2012-09-20 2020-07-01 Prothera Inc Composiciones probióticas para el tratamiento de la obesidad y afecciones relacionadas con la obesidad
KR101545551B1 (ko) 2013-12-12 2015-08-19 주식회사한국야쿠르트 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
KR101426275B1 (ko) 2014-04-04 2014-08-06 주식회사한국야쿠르트 지방합성 억제 및 지방산화 촉진에 의한 체지방 감소 효능을 갖는 5종의 유산균 복합균주를 유효성분으로 함유하는 조성물
JP6524432B2 (ja) * 2014-05-29 2019-06-05 日東薬品工業株式会社 新規乳酸菌及び該乳酸菌を含む組成物
EP3172973B1 (en) * 2015-11-27 2020-04-08 DAFLORN Ltd. Probiotic formula, process of its preparation and use
BR112018070518A2 (pt) * 2016-04-14 2019-01-29 Dupont Nutrition Biosci Aps bactéria do gênero bifidobacterium, usos de uma bactéria do gênero bifidobacterium e método para reduzir a ingestão de alimentos, energia e/ou gordura
WO2018174125A1 (ja) * 2017-03-22 2018-09-27 雪印メグミルク株式会社 脂質代謝改善用組成物
KR102218992B1 (ko) 2017-12-12 2021-02-23 한국생명공학연구원 아가토바쿨룸 속 균주를 유효성분으로 함유하는 자폐 범주성 장애의 예방, 개선 또는 치료용 조성물
KR102021881B1 (ko) * 2018-09-07 2019-09-17 재단법인 전남생물산업진흥원 스트렙토코커스 써모필러스 lm1012 균주 및 이를 포함하는 염증 질환 또는 대사 질환의 예방 또는 치료용 조성물
CN113025527A (zh) * 2021-03-25 2021-06-25 上海市第十人民医院 一种用来预测婴幼儿肥胖病的乳源性唾液链球菌及其分离方法
JP2023145882A (ja) * 2022-03-29 2023-10-12 雪印メグミルク株式会社 Ｉａｐ活性化用組成物
CN115181698B (zh) * 2022-06-28 2023-09-08 广东粤港澳大湾区国家纳米科技创新研究院 一种益生菌组合物及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61221124A (ja) * 1985-03-26 1986-10-01 Advance Res & Dev Co Ltd 肝機能改善剤
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
US6297229B1 (en) 1994-11-14 2001-10-02 Mayo Foundation For Medical Education And Research Use of ursodeoxycholic acid to treat nonalcoholic steatohepatitis
US5760010A (en) 1995-01-01 1998-06-02 Klein; Ira Method of treating liver disorders with a macrolide antibiotic
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
MY117168A (en) * 1997-12-05 2004-05-31 Viva America Marketing Inc Composition and method for treating nonalcoholic steatohepatitis
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.

Also Published As

Publication number Publication date
NO20033621D0 (no) 2003-08-14
US20070253934A1 (en) 2007-11-01
NO329645B1 (no) 2010-11-22
CN1875994A (zh) 2006-12-13
PT1456351E (pt) 2006-10-31
PL370252A1 (en) 2005-05-16
HK1100165A1 (zh) 2007-09-07
BR0207397A (pt) 2004-02-10
IS7229A (is) 2004-04-21
CY1105402T1 (el) 2010-04-28
IL161995A0 (en) 2005-11-20
EP1456351B1 (en) 2006-08-09
CN1558946A (zh) 2004-12-29
MA27685A1 (fr) 2006-01-02
WO2003055984A1 (en) 2003-07-10
HU225787B1 (hu) 2007-09-28
NO20033621L (no) 2003-08-14
KR20040074053A (ko) 2004-08-21
IL161995A (en) 2010-11-30
CN1276970C (zh) 2006-09-27
EP1652913A1 (en) 2006-05-03
PL207395B1 (pl) 2010-12-31
CN100502893C (zh) 2009-06-24
AU2002367124B2 (en) 2007-11-29
NZ533696A (en) 2005-12-23
ATE335807T1 (de) 2006-09-15
CA2457801C (en) 2013-06-04
EA006688B1 (ru) 2006-02-24
IS2645B (is) 2010-08-15
DK1456351T3 (da) 2006-12-11
US7223591B2 (en) 2007-05-29
HK1072958A1 (en) 2005-09-16
ES2271384T3 (es) 2007-04-16
UA80546C2 (en) 2007-10-10
DE60213859T2 (de) 2007-02-08
ZA200405763B (en) 2006-07-26
JP2005512590A (ja) 2005-05-12
ITRM20010763A1 (it) 2003-06-21
CA2457801A1 (en) 2003-07-10
JP2009183296A (ja) 2009-08-20
MXPA03007483A (es) 2003-12-04
HUP0402460A3 (en) 2005-04-28
EA200400845A1 (ru) 2004-12-30
EP1456351A1 (en) 2004-09-15
JP4339124B2 (ja) 2009-10-07
AU2002367124A1 (en) 2003-07-15
US7628981B2 (en) 2009-12-08
DE60213859D1 (de) 2006-09-21
KR100934747B1 (ko) 2009-12-30
HUP0402460A2 (hu) 2005-03-29
US20040248278A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
AR038036A1 (es) Nueva cepa de bacterias del acido lactico y composiciones comestibles, drogas y productos veterinarios que la contienen
AR086677A2 (es) Composicion de bacterias de acido lactico y su uso para hacer un suplemento alimentario de higiene o farmaceutica para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias
GB0124580D0 (en) New composition
ATE421256T1 (de) Probiotische zusammensetzung
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
UA93911C2 (ru) Применение бактериального штамма lactobacillus reuteri dsm 17938 для снижения колик у грудных детей
AR042313A1 (es) Composicion bacteriana y su uso para inmunomudulacion y prevencion de la enfermedad inflamatoria intestinal
SE9702083L (sv) Farmaceutisk beredning för bekämpning av patogena tarmbakterier
AR035683A1 (es) Producto de consumo que contiene probioticos
HUP0100428A3 (en) Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
IL156490A0 (en) Probiotic compounds derived from lactobacillus casei strain ke01
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
UA111715C2 (uk) Композиція, що містить пробіотичні бактерії для застосування у лікуванні імунних розладів
AR009546A1 (es) Helado de crema que contiene bacterias lacticas vivas
IL181601A0 (en) Ferulate esterase producing strains and methods of using same
ATE367821T1 (de) Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
PE20040419A1 (es) Un producto lacteo y un proceso para su fabricacion
Paik et al. Characterization of Bacillus polyfermenticus SCD for oral bacteriotherapy of gastrointestinal disorders
AR130337A1 (es) Cepa de bacillus, variantes de la misma, productos de fermentación y composiciones de los mismos para la inhibición de enfermedades de las plantas
GR3032933T3 (en) Inhibition of clostridia with lactic acid bacteria
AU2002362549A1 (en) Novel lactic acid bacteria of the genus lactococcus lactis and use thereof for preserving food products
GB2319728A (en) Protection against pathogenic microorganisms
ITMO20020001A1 (it) Lactobacillo per la preservazione di prodotti vegetali di iv gamma, loro miscele, derivati di prodotti vegetali di iv gamma e loro miscele
JPS642570A (en) Bacillus subtilis strain and elimination of aflatoxin contamination using said strain
BG105453U (en) Probiotic food additive

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee